These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36134566)

  • 1. Regulated Necrosis in Atherosclerosis.
    Puylaert P; Zurek M; Rayner KJ; De Meyer GRY; Martinet W
    Arterioscler Thromb Vasc Biol; 2022 Nov; 42(11):1283-1306. PubMed ID: 36134566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage Death as a Pharmacological Target in Atherosclerosis.
    Martinet W; Coornaert I; Puylaert P; De Meyer GRY
    Front Pharmacol; 2019; 10():306. PubMed ID: 31019462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets.
    De Meyer GRY; Zurek M; Puylaert P; Martinet W
    Nat Rev Cardiol; 2024 May; 21(5):312-325. PubMed ID: 38163815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis.
    Lin L; Zhang MX; Zhang L; Zhang D; Li C; Li YL
    Front Cell Dev Biol; 2021; 9():809955. PubMed ID: 35096837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modulation of cell death in atherosclerosis: a promising approach towards plaque stabilization?
    Martinet W; Schrijvers DM; De Meyer GR
    Br J Pharmacol; 2011 Sep; 164(1):1-13. PubMed ID: 21418184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis.
    Coornaert I; Hofmans S; Devisscher L; Augustyns K; Van Der Veken P; De Meyer GRY; Martinet W
    Expert Opin Drug Discov; 2018 Jun; 13(6):477-488. PubMed ID: 29598451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis.
    Karunakaran D; Geoffrion M; Wei L; Gan W; Richards L; Shangari P; DeKemp EM; Beanlands RA; Perisic L; Maegdefessel L; Hedin U; Sad S; Guo L; Kolodgie FD; Virmani R; Ruddy T; Rayner KJ
    Sci Adv; 2016 Jul; 2(7):e1600224. PubMed ID: 27532042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrotic cell death in atherosclerosis.
    Martinet W; Schrijvers DM; De Meyer GR
    Basic Res Cardiol; 2011 Sep; 106(5):749-60. PubMed ID: 21611880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage death in atherosclerosis: potential role in calcification.
    Neels JG; Gollentz C; Chinetti G
    Front Immunol; 2023; 14():1215612. PubMed ID: 37469518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis.
    Rasheed A; Robichaud S; Nguyen MA; Geoffrion M; Wyatt H; Cottee ML; Dennison T; Pietrangelo A; Lee R; Lagace TA; Ouimet M; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1155-1167. PubMed ID: 32212851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.
    Kowara M; Cudnoch-Jedrzejewska A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Efferocytosis in Atherosclerotic Lesions In Situ.
    Yurdagul A
    Methods Mol Biol; 2022; 2419():561-567. PubMed ID: 35237988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.
    Sastre C; Fernández-Laso V; Madrigal-Matute J; Muñoz-García B; Moreno JA; Pastor-Vargas C; Llamas-Granda P; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
    J Cell Mol Med; 2014 Apr; 18(4):721-34. PubMed ID: 24479820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis.
    Perrotta P; Emini Veseli B; Van der Veken B; Roth L; Martinet W; De Meyer GRY
    Vascul Pharmacol; 2019 Jan; 112():72-78. PubMed ID: 29933080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture.
    Bobryshev YV; Killingsworth MC; Lord RS; Grabs AJ
    J Cell Mol Med; 2008 Oct; 12(5B):2073-82. PubMed ID: 18194456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods and models for monitoring UPR-associated macrophage death during advanced atherosclerosis.
    Thorp EB
    Methods Enzymol; 2011; 489():277-96. PubMed ID: 21266236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress.
    Tabas I
    Antioxid Redox Signal; 2009 Sep; 11(9):2333-9. PubMed ID: 19243235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatially Resolved Metabolites in Stable and Unstable Human Atherosclerotic Plaques Identified by Mass Spectrometry Imaging.
    Seeley EH; Liu Z; Yuan S; Stroope C; Cockerham E; Rashdan NA; Delgadillo LF; Finney AC; Kumar D; Das S; Razani B; Liu W; Traylor J; Orr AW; Rom O; Pattillo CB; Yurdagul A
    Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):1626-1635. PubMed ID: 37381983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.